JP2024524514A5 - - Google Patents
Info
- Publication number
- JP2024524514A5 JP2024524514A5 JP2024500032A JP2024500032A JP2024524514A5 JP 2024524514 A5 JP2024524514 A5 JP 2024524514A5 JP 2024500032 A JP2024500032 A JP 2024500032A JP 2024500032 A JP2024500032 A JP 2024500032A JP 2024524514 A5 JP2024524514 A5 JP 2024524514A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2021/055958 WO2023275601A1 (en) | 2021-07-02 | 2021-07-02 | A novel rna-programmable system for targeting polynucleotides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024524514A JP2024524514A (ja) | 2024-07-05 |
| JPWO2023275601A5 JPWO2023275601A5 (https=) | 2024-07-12 |
| JP2024524514A5 true JP2024524514A5 (https=) | 2024-07-12 |
Family
ID=76859656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500032A Pending JP2024524514A (ja) | 2021-07-02 | 2021-07-02 | ポリヌクレオチドを標的とする新規ｒｎａプログラム可能システム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240368630A1 (https=) |
| EP (1) | EP4363566A1 (https=) |
| JP (1) | JP2024524514A (https=) |
| KR (1) | KR20240027724A (https=) |
| WO (1) | WO2023275601A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116355878B (zh) * | 2023-02-28 | 2024-04-26 | 华中农业大学 | 新型TnpB编程性核酸酶及其应用 |
| CN116355938A (zh) * | 2023-03-01 | 2023-06-30 | 山东大学 | 基于微型RNA引导核酸酶TnpB的基因编辑载体系统及其构建方法和应用 |
| WO2024192291A1 (en) | 2023-03-15 | 2024-09-19 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| WO2024199134A1 (en) * | 2023-03-27 | 2024-10-03 | Beijing Astragenomics Technology Co., Ltd. | Isolated nuclease and use thereof |
| AU2024335327A1 (en) | 2023-09-01 | 2026-03-26 | Renagade Therapeutics Management Inc. | Gene editing systems, compositions, and methods for treatment of vexas syndrome |
| CN116970590B (zh) * | 2023-09-22 | 2024-01-30 | 北京科芙兰德生物科学有限责任公司 | 小于380个氨基酸的超级迷你型基因编辑器及其应用 |
| WO2025117544A1 (en) * | 2023-11-29 | 2025-06-05 | The Broad Institute, Inc. | Engineered omega guide molecule and iscb compositions, systems, and methods of use thereof |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3012607A1 (en) * | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Crispr enzymes and systems |
| EP4159856A1 (en) * | 2015-06-18 | 2023-04-05 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
| US12431216B2 (en) * | 2016-08-17 | 2025-09-30 | Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
| US20230040216A1 (en) * | 2019-11-19 | 2023-02-09 | The Broad Institute, Inc. | Retrotransposons and use thereof |
| EP4281567A4 (en) * | 2021-01-25 | 2025-03-05 | The Broad Institute Inc. | REPROGRAMMABLE TNPB POLYPEPTIDES AND THEIR USE |
-
2021
- 2021-07-02 WO PCT/IB2021/055958 patent/WO2023275601A1/en not_active Ceased
- 2021-07-02 US US18/575,173 patent/US20240368630A1/en active Pending
- 2021-07-02 JP JP2024500032A patent/JP2024524514A/ja active Pending
- 2021-07-02 EP EP21740202.3A patent/EP4363566A1/en active Pending
- 2021-07-02 KR KR1020247002706A patent/KR20240027724A/ko active Pending